Rasburicase in Tumor Lysis Syndrome
NCT00302653
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
33
Enrollment
INDUSTRY
Sponsor class
Conditions
Hyperuricemia
Interventions
DRUG:
Rasburicase
Sponsor
Sanofi